Akoya Biosciences, Inc. (AKYA)
NASDAQ: AKYA · Real-Time Price · USD
1.430
-0.060 (-4.03%)
At close: Mar 28, 2025, 4:00 PM
1.427
-0.003 (-0.21%)
After-hours: Mar 28, 2025, 7:15 PM EDT
Akoya Biosciences Analyst Ratings
Total Analysts
7
Consensus Rating
Buy
Price Target
$3.26
Upside
+127.97%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stephens & Co. | Stephens & Co. | Buy → Hold Downgrades $3.5 → $1.8 | Buy → Hold | Downgrades | $3.5 → $1.8 | +25.87% | Mar 25, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $3.5 | Buy | Reiterates | $3.5 | +144.76% | Mar 18, 2025 |
| Piper Sandler | Piper Sandler | Buy Reiterates $4 → $3 | Buy | Reiterates | $4 → $3 | +109.79% | Nov 19, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy → Hold Downgrades $7 → $5 | Strong Buy → Hold | Downgrades | $7 → $5 | +249.65% | Nov 15, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $6 → $3.5 | Strong Buy | Maintains | $6 → $3.5 | +144.76% | Nov 15, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $6 → $4 | Buy | Maintains | $6 → $4 | +179.72% | Aug 13, 2024 |
| Morgan Stanley | Morgan Stanley | Buy → Hold Downgrades $4 → $3 | Buy → Hold | Downgrades | $4 → $3 | +109.79% | Aug 6, 2024 |
| BTIG | BTIG | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 6, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $7.5 → $7 | Strong Buy | Maintains | $7.5 → $7 | +389.51% | Aug 6, 2024 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Aug 6, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $8 → $4 | Buy | Maintains | $8 → $4 | +179.72% | Jun 3, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $10 → $6 | Strong Buy | Maintains | $10 → $6 | +319.58% | May 14, 2024 |
| BTIG | BTIG | Strong Buy Maintains $9 → $6 | Strong Buy | Maintains | $9 → $6 | +319.58% | May 14, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $12 → $10 | Buy | Maintains | $12 → $10 | +599.30% | Mar 6, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +599.30% | Mar 5, 2024 |
| UBS | UBS | Strong Buy Maintains $7 → $7.5 | Strong Buy | Maintains | $7 → $7.5 | +424.48% | Mar 5, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.